From: Long-term prognostic outcomes in patients with haemoptysis
Final diagnosis | Events | Patients | Mild | Moderate | Severe |
---|---|---|---|---|---|
Bronchiectasis, n (%) | 45 | 28 (27.2) | 20 (71.4) | 6 (21.4) | 2 (7.1) |
Pulmonary malignancy, n (%) | 30 | 24 (23.3) | 11(36.6) | 11 (36.6) | 2 (0.8) |
Lung cancer, n (%) | 26 | 22 (21.4) | 10 (45.5) | 10 (45.5) | 2 (9.1) |
Pulmonary metastasis, n (%) | 4 | 2 (1.9) | 1 (50.0) | 1 (50.0) | 0 (0.0) |
Pneumonia/lung abscess, n (%) | 21 | 13 (12.6) | 13 (100) | 0 (0.0) | 0 (0.0) |
COPD (exacerbation), n (%) | 13 | 7 (6.8) | 7 (100.0) | 0 (0.0) | 0 (0.0) |
Acute bronchitis, n (%) | 11 | 7 (6.8) | 7 (100.0) | 0 (0.0) | 0 (0.0) |
Cryptogenic haemoptysis, n (%) | 10 | 6 (5.8) | 5 (83.3) | 1 (16.7) | 0 (0.0) |
Upper airways bleeding disease, n (%) | 8 | 4 (3.9) | 2 (50.0) | 2 (50.0) | 0 (0.0) |
Post-tuberculosis sequelae, n (%) | 8 | 3 (2.9) | 2 (66.7) | 1 (33.3) | 0 (0.0) |
Other pulmonary/bronchial vascular lesion, n (%) | 5 | 2 (1.9) | 1 (50.0) | 0 (0.0) | 1 (50.0) |
Pulmonary embolism, n (%) | 5 | 2 (1.9) | 1 (50.0) | 1 (50.0) | 0 (0.0) |
Atypical mycobacteriosis, n (%) | 2 | 1 (1.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) |
Active tuberculosis, n (%) | 2 | 2 (1.9) | 1 (50.0) | 1 (50.0) | 0 (0.0) |
Iatrogenic or traumatic, n (%) | 2 | 1 (1.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) |
Tracheal granuloma, n (%) | 2 | 1 (1.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) |
Hematemesis, n (%) | 1 | 1 (1.0) | 0 (0.0) | 1 (100.0) | 0 (0.0) |
Interstitial lung disease, n (%) | 1 | 1 (1.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) |